These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Use of a yeast-based membrane protein expression technology to overexpress drug resistance efflux pumps. Lamping E, Cannon RD. Methods Mol Biol; 2010; 666():219-50. PubMed ID: 20717788 [Abstract] [Full Text] [Related]
10. Characterization of the multi-drug efflux systems of pathogenic fungi using functional hyperexpression in Saccharomyces cerevisiae. Niimi M. Nihon Ishinkin Gakkai Zasshi; 2010; 51(2):79-86. PubMed ID: 20467195 [Abstract] [Full Text] [Related]
12. Beauvericin Potentiates Azole Activity via Inhibition of Multidrug Efflux, Blocks Candida albicans Morphogenesis, and Is Effluxed via Yor1 and Circuitry Controlled by Zcf29. Shekhar-Guturja T, Tebung WA, Mount H, Liu N, Köhler JR, Whiteway M, Cowen LE. Antimicrob Agents Chemother; 2016 Dec; 60(12):7468-7480. PubMed ID: 27736764 [Abstract] [Full Text] [Related]
14. Modulation of the antifungal activity of new medicinal plant extracts active on Candida glabrata by the major transporters and regulators of the pleiotropic drug-resistance network in Saccharomyces cerevisiae. Kolaczkowski M, Kolaczkowska A, Stermitz FR. Microb Drug Resist; 2009 Mar; 15(1):11-7. PubMed ID: 19216644 [Abstract] [Full Text] [Related]
19. Candida albicans AGE3, the ortholog of the S. cerevisiae ARF-GAP-encoding gene GCS1, is required for hyphal growth and drug resistance. Lettner T, Zeidler U, Gimona M, Hauser M, Breitenbach M, Bito A. PLoS One; 2010 Aug 05; 5(8):e11993. PubMed ID: 20700541 [Abstract] [Full Text] [Related]